Summary: Stanford researchers at the Melosh Lab have proposed a non-invasive, high electrode density, high resolution (100 micrometers to 10 nanometers) neural device implantation for electrical stimulation of neural/biological tissues.
Researchers at Stanford have developed methods to identify and treat MYC-driven cancers, including renal cell carcinoma (RCC). RCC is a common, aggressive type of kidney cancer and effective therapeutics are lacking.
Stanford researchers patented a method to design, computationally optimize and fabricate efficient optical devices using semiconducting and dielectric nanostructures.
Stanford researchers have developed an injectable, biocompatible hydrogel consisting of extracellular matrix (ECM) from human cadaveric tendons as a potential scaffold for guided tissue regeneration and tissue engineering purposes.
This invention, the “Charge Cloud Tracker” is a fast, low-cost, strip geometry x-ray detector that is predicted to provide limiting resolution on the order of 5 microns, with very high x-ray detection efficiency.
Researchers in Prof. Karl Deisseroth's laboratory have developed a highly precise, scalable optical system for imaging or controlling thousands of individual neurons in the 3D volume accessible with a single multiphoton fluorescent microscope objective.
Researchers in Prof. Sylvia Plevritis' laboratory have developed an algorithm designed to optimize cancer combination therapy for individual patients by analyzing distinct single-cell responses from heterogeneous tumors.
A team of researchers at Stanford and the University of Connecticut have developed a method to deliver contrast agents through a patient-friendly sublingual or buccal film that provides prolonged continuous release for ongoing optical imaging.
Stanford researchers have designed a method to increase the photoyield of thin film CsBr/metal photocathodes by activation with electron bombardment, allowing efficient operation at UV and longer incident light wavelengths.
Stanford researchers have invented a fully water-soluble, orange hydrazine sensor that can robustly quantify the toxin hydrazine in liquids such as drinking water, waste water (treated and untreated), and bodily fluids.
Researchers in Dr. Jianghong Rao's lab have developed nanoprobes for monitoring drug-induced hepatotoxicity in vivo in real time. Drug toxicity is a long-standing concern of modern medicine.